P-189 Correlation between of expression of the enzyme topoisomerase I and p53 and result of irinotecan based therapy in patients with metastatic colorectal cancer von Pasic, A., Beslija, S., Djuran, A., Sefic-Pasic, I., Banjin, M., Ceric, T., Rasic, A., Hasanbegovic, B., Jalovcic, A., Kapisazovic, E.

Volltext

Effects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results von Beslija, S., Ceric, T., Hasanbegovic, B., Skenderi, F., Alidžanović, J., Kopric, D., Marjanović, I., Mekic-Abazovic, A., Sisic, I.S., Hammami, M., Pasic, A., Rasic, A., Kapisazović, E.

Volltext

200P - Effects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results von Beslija, S., Ceric, T., Hasanbegovic, B., Skenderi, F., Alidžanović, J., Kopric, D., Marjanović, I., Mekic-Abazovic, A., Sisic, I.S., Hammami, M., Pasic, A., Rasic, A., Kapisazović, E.

Volltext

200PEffects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results von Beslija, S, Ceric, T, Hasanbegovic, B, Skenderi, F, Alidžanović, J, Kopric, D, Marjanović, I, Mekic-Abazovic, A, Sisic, I S, Hammami, M, Pasic, A, Rasic, A, Kapisazović, E

Volltext